Basic immunology of antibody targeted radiotherapy

Int J Radiat Oncol Biol Phys. 2006;66(2 Suppl):S8-14. doi: 10.1016/j.ijrobp.2005.05.056.

Abstract

Antibody targeted radiotherapy brings an important new treatment modality to the radiation oncology clinic. Radiation dose to tumor and normal tissues are determined by a complex interplay of antibody, antigen, tumor, radionuclide, and host-related factors. A basic understanding of these immunologic and physiologic factors is important to optimally utilize this therapy in the clinic. Preclinical and clinical studies need to be continued to broaden our understanding and to develop new strategies to further improve the efficacy of this promising form of targeted therapy.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / chemistry
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibody Specificity
  • Antigens, Neoplasm / immunology
  • Humans
  • Molecular Weight
  • Neoplasms / radiotherapy
  • Radioimmunotherapy / methods*
  • Radioisotopes / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Radioisotopes